Prime Capital Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Sell |
2,996
-735
| -20% | -$327K | 0.02% | 415 |
|
|
2025
Q1 | $1.81M | Buy |
3,731
+750
| +25% | +$364K | 0.02% | 386 |
|
|
2024
Q4 | $1.2M | Sell |
2,981
-475
| -14% | -$191K | 0.02% | 396 |
|
|
2024
Q3 | $1.61M | Buy |
3,456
+78
| +2% | +$36.3K | 0.02% | 352 |
|
|
2024
Q2 | $1.58M | Sell |
3,378
-734
| -18% | -$344K | 0.02% | 342 |
|
|
2024
Q1 | $1.72M | Buy |
4,112
+718
| +21% | +$300K | 0.02% | 370 |
|
|
2023
Q4 | $1.38M | Buy |
3,394
+1,741
| +105% | +$708K | 0.02% | 382 |
|
|
2023
Q3 | $575K | Sell |
1,653
-993
| -38% | -$345K | 0.01% | 444 |
|
|
2023
Q2 | $931K | Buy |
2,646
+1,808
| +216% | +$636K | 0.02% | 370 |
|
|
2023
Q1 | $264K | Buy |
838
+35
| +4% | +$11K | 0.01% | 448 |
|
|
2022
Q4 | $232K | Buy |
+803
| New | +$232K | 0.01% | 467 |
|
|
2019
Q4 | – | Sell |
-60
| Closed | -$10K | – | 649 |
|
|
2019
Q3 | $10K | Buy |
+60
| New | +$10K | ﹤0.01% | 521 |
|